VIA

Virtus Investment Advisers Portfolio holdings

AUM $368M
1-Year Est. Return 26.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+26.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$349M
AUM Growth
+$53.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
478
New
Increased
Reduced
Closed

Top Buys

1
+$2.36M
2
+$1.99M
3
+$1.97M
4
IDXX icon
Idexx Laboratories
IDXX
+$1.96M
5
TKO icon
TKO Group
TKO
+$1.96M

Top Sells

1
+$1.85M
2
+$1.62M
3
+$1.62M
4
CBRE icon
CBRE Group
CBRE
+$1.61M
5
NU icon
Nu Holdings
NU
+$1.58M

Sector Composition

1 Financials 33.25%
2 Healthcare 17.27%
3 Technology 14.61%
4 Industrials 8.9%
5 Consumer Discretionary 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DYN icon
426
Dyne Therapeutics
DYN
$2.57B
$99.5K 0.03%
7,869
+1,366
NGNE icon
427
Neurogene
NGNE
$364M
$96.7K 0.03%
5,578
+969
SLNO icon
428
Soleno Therapeutics
SLNO
$2.1B
$95.9K 0.03%
1,419
+247
AVBP icon
429
ArriVent BioPharma
AVBP
$948M
$88.9K 0.03%
4,816
+837
NRIX icon
430
Nurix Therapeutics
NRIX
$1.64B
$87.9K 0.03%
9,514
+1,652
AUTL
431
Autolus Therapeutics
AUTL
$455M
$86.3K 0.02%
52,924
+9,188
MREO
432
Mereo BioPharma
MREO
$59M
$84.3K 0.02%
40,930
+7,105
TRDA icon
433
Entrada Therapeutics
TRDA
$456M
$84.1K 0.02%
14,495
+2,516
TECX
434
Tectonic Therapeutic
TECX
$439M
$79.6K 0.02%
5,071
+881
CGEM icon
435
Cullinan Oncology
CGEM
$916M
$75.4K 0.02%
12,714
+2,208
ALT icon
436
Altimmune
ALT
$540M
$60K 0.02%
15,914
+2,763
CAPR icon
437
Capricor Therapeutics
CAPR
$1.52B
$58.9K 0.02%
8,163
+1,417
REPL icon
438
Replimune Group
REPL
$632M
$48.2K 0.01%
11,511
+1,998
MLTX icon
439
MoonLake Immunotherapeutics
MLTX
$1.24B
$18.5K 0.01%
2,585
+449
NU icon
440
Nu Holdings
NU
$72.6B
– –
-115,382
OKTA icon
441
Okta
OKTA
$12.8B
– –
-13,406
ACGL icon
442
Arch Capital
ACGL
$36B
– –
-15,279
AFL icon
443
Aflac
AFL
$58.6B
– –
-12,839
BGX
444
Blackstone Long-Short Credit Income Fund
BGX
$138M
– –
-56,944
CBRE icon
445
CBRE Group
CBRE
$43.6B
– –
-11,480
CPRT icon
446
Copart
CPRT
$36.9B
– –
-22,755
CTSH icon
447
Cognizant
CTSH
$30.8B
– –
-19,203
ECL icon
448
Ecolab
ECL
$86.9B
– –
-5,819
EFR
449
Eaton Vance Senior Floating-Rate Fund
EFR
$315M
– –
-65,479
EXPE icon
450
Expedia Group
EXPE
$26.4B
– –
-8,656
16 17
18
19 20